Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

CCDC39 Inhibitors

CCDC39, standing for Coiled-Coil Domain Containing 39, is a protein encoded by the CCDC39 gene in humans. This protein is recognized for its role in the structure and function of motile cilia. These are hair-like projections found on the surface of certain cells and are essential for movement and fluid flow across cell surfaces. The presence of a coiled-coil domain suggests that CCDC39 likely acts as a scaffold protein, promoting the assembly or stability of multi-protein complexes.The significance of CCDC39 is particularly evident in its association with primary ciliary dyskinesia (PCD), a genetic disorder characterized by chronic respiratory tract infections, abnormal organ positioning, and fertility issues. Mutations in the CCDC39 gene lead to defects in the formation and function of cilia, underlying the manifestations of PCD.

At the molecular level, CCDC39 is integral to the assembly and maintenance of the axoneme-the core structural component of cilia and flagella. It is involved in the proper alignment and attachment of the dynein arms, which are motor proteins that drive the beating of cilia through ATP hydrolysis. Therefore, CCDC39 is vital for the cilia's motility, and its absence or malfunction results in impaired ciliary movement.Research has shown that CCDC39 interacts with other cytoskeletal and scaffolding proteins, implicating a complex network of interactions necessary for ciliary function. It is believed to be a component of the "ruler" complex that determines the ciliary 9+2 microtubule arrangement, a hallmark of motile cilia.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, an mTOR inhibitor, might indirectly affect CCDC39 by modulating cellular growth and autophagy processes, potentially influencing proteins involved in these pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, a PI3K inhibitor, can affect various signaling pathways, potentially altering the expression or function of proteins like CCDC39 involved in cellular processes regulated by PI3K.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580, by inhibiting p38 MAPK, could indirectly influence CCDC39 function, as p38 MAPK is key in inflammatory responses and stress-induced pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3K inhibitor, may alter CCDC39-related pathways by affecting cellular processes like growth, survival, and metabolism.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059, an inhibitor of MEK, may indirectly modulate CCDC39 activity by influencing the MAPK/ERK pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125, a JNK inhibitor, might affect CCDC39 indirectly by modulating cellular stress responses and apoptosis pathways.

LY3214996

1951483-29-6sc-507299
5 mg
$265.00
(0)

LY3214996, an ERK1/2 inhibitor, potentially impacts CCDC39 indirectly by modulating signaling pathways involved in cell proliferation and differentiation.

PP242

1092351-67-1sc-301606A
sc-301606
1 mg
5 mg
$57.00
$172.00
8
(1)

Torin 1, an mTOR inhibitor like Rapamycin, can indirectly affect the function or expression of CCDC39 by altering cellular growth and autophagy pathways.

BIX 02189

1094614-85-3sc-364436
sc-364436A
5 mg
10 mg
$224.00
$386.00
5
(1)

BIX 02189, a MEK5 inhibitor, might indirectly influence CCDC39 through pathways involving the ERK5/MAPK7 cascade.

Selumetinib

606143-52-6sc-364613
sc-364613A
sc-364613B
sc-364613C
sc-364613D
5 mg
10 mg
100 mg
500 mg
1 g
$29.00
$82.00
$420.00
$1897.00
$3021.00
5
(1)

Selumetinib, a MEK inhibitor, could indirectly affect CCDC39 by modulating the MAPK/ERK pathway, impacting cell growth and differentiation.